| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/08/2006 | CN1742721A Mitiglinide preparation and preparing method |
| 03/08/2006 | CN1742713A Method for preparing sodium ferulate sterilized raw-material medicine |
| 03/08/2006 | CN1742709A Method for extracting high-content solanesol extract by liquid-liquid two-phase method |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244573C Benzofuran category compound, its preparing method and usage |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244343C Chinese medicine fat-reducing liniment and preparation method thereof |
| 03/08/2006 | CN1244337C Natural medicated health food for preventing and treating diabetes and cardiac vascular diseases induced thereby |
| 03/08/2006 | CN1244326C Fatigue-resistant drug composition |
| 03/08/2006 | CN1244324C Reforming effect of arginine to recessive harm of skin tissue of diabetes |
| 03/08/2006 | CN1244323C Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 03/08/2006 | CN1244281C Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009057 Method for obtaining pioglitazone as an antidiabetic agent |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008648 Solvent extraction, distillation biomass |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | CA2332983C Sitostanol formulation with emulsifier to reduce cholesterol absorption |
| 03/02/2006 | WO2006023865A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | WO2006023630A2 The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| 03/02/2006 | WO2006023295A2 Pharmaceutical compositions comprising effervescent agents and fenofibrate |
| 03/02/2006 | WO2006023121A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in white adipose tissue (13) |
| 03/02/2006 | WO2006022428A1 Remedy for diabetes |
| 03/02/2006 | WO2006022420A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006022356A1 Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 03/02/2006 | WO2006022338A1 Dry powder of pseudo leaf tissue of plant belonging to the genus asparagus |
| 03/02/2006 | WO2006022314A1 Cholesterol metabolism controller and foods, drinks, food additives and drugs containing the same |
| 03/02/2006 | WO2006022227A1 Lipase inhibitor |
| 03/02/2006 | WO2006022187A1 Coenzyme q10-containing composition |
| 03/02/2006 | WO2006022091A1 Method of culturing human bone marrow-origin mesenchymal stem cells using human serum medium |
| 03/02/2006 | WO2006021657A1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof |
| 03/02/2006 | WO2005100990A3 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) |
| 03/02/2006 | WO2005089730A3 Dna pkinase inhibitors for treating cancer and diabetes |
| 03/02/2006 | WO2005023253A8 Use of pde4 inhibitors for the treatment of diabetes mellitus |
| 03/02/2006 | WO2005019429A3 Compositions and methods for enhancing phagocytosis or phagocyte activity |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | US20060045874 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 03/02/2006 | US20060045853 Using tissue plasminogen activator finger domain specific immunolglobulins as tool in diagnosis of diabbetes and/or alzheimer's disease |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | DE102004040736A1 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
| 03/02/2006 | DE102004040168A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis) |
| 03/02/2006 | DE102004039789A1 Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-substituted polycyclic amines, process for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039533A1 Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexylmethoxy-acetic acid derivatives having substituents, processes for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039532A1 Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexyl-methyloxy-substituted acetic acid derivatives, process for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039507A1 Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-Aminoalkoxi-xanthines, processes for their preparation and their use as medicaments |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577857A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | CA2577676A1 Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil |
| 03/02/2006 | CA2577373A1 Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
| 03/02/2006 | CA2576465A1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/02/2006 | CA2575461A1 The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| 03/02/2006 | CA2574517A1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof |
| 03/02/2006 | CA2574454A1 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
| 03/01/2006 | EP1630152A1 Condensed ring compound |
| 03/01/2006 | EP1629851A1 Remedy for diabetes |
| 03/01/2006 | EP1629849A2 Pharmaceutical compositions comprising exendins and agonists thereof |
| 03/01/2006 | EP1629840A1 Amino acid composition and fluid replacement |
| 03/01/2006 | EP1629729A2 Use of a crosslinked or inhibited starch product |
| 03/01/2006 | EP1629728A1 Use of chemically modified starch product |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628970A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 03/01/2006 | EP1628968A1 4-imidazolin-2-one compounds |
| 03/01/2006 | EP1628676A1 Grf analog compositions and their use |
| 03/01/2006 | EP1628622A2 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 03/01/2006 | EP1494691A4 Treatment of diseases involving defective gap junctional communication |
| 03/01/2006 | EP1472255B1 Aza-arylpiperazines |
| 03/01/2006 | EP1455774B1 Pharmaceutical composition for treating obesity |
| 03/01/2006 | EP1414426B1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1345942B1 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1244433B1 Use of non-human SHIP2 knock-out mammals |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1141252B1 Human delta 5-desaturase gene and uses thereof |
| 03/01/2006 | EP0981364B1 Method and compositions for treating hyperlipidemia |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1741984A CaSR antagonist |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741819A Sustained release composition for oral administration of drugs |
| 03/01/2006 | CN1741805A High protein, bowman-birk inhibitor concentrate and process for its manufacture |
| 03/01/2006 | CN1741799A Combination of antidiabetic drugs |
| 03/01/2006 | CN1741798A Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 03/01/2006 | CN1740787A Method for measuring total flavone content in compositions extracted from gingko biloba leaves |
| 03/01/2006 | CN1740786A Method for measuring tepene lactone content in compositions extracted from Ginkgo biloba leaves |
| 03/01/2006 | CN1740198A GLP-1 derivative |
| 03/01/2006 | CN1740195A Polypeptide gapM1 and its prepn process |
| 03/01/2006 | CN1740182A Novel bisamidate phosphonate prodrugs |
| 03/01/2006 | CN1739805A Composition and method of diagnosing and treating type-II diabetes and sugar tolerance abnormality |
| 03/01/2006 | CN1739798A Biodegradable chewing gum with functions of nursing face, beautifying and slimming |